ERK-MAPK signaling opposes rho-kinase to reduce cardiomyocyte apoptosis in heart ischemic preconditioning

Molecular Medicine

Volumn 16, Issue 7-8, 2010, Pages 307-315

  Juan Zhang, ^a   Bian, Hong Jun ^a   Li, Xiao Xing ^a   Liu, Xiao Bo ^b   Sun, Jun Ping ^c   Na Li, ^a   Yun Zhang, ^a   Ji, Xiao Ping ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Blood Center   (China)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RHO KINASE; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEART INFARCTION; METABOLISM; MYOCARDIAL REPERFUSION INJURY; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVONOIDS; IN SITU NICK-END LABELING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MAP KINASE SIGNALING SYSTEM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN;

EID: 77954250539     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00121     Document Type: Article

References (34)

1. Amano M, et al. (1997) Formation of actin stress fibers and focal adhesions enhanced by Rhokinase. Science. 275:1308-11.
2. Yasui Y, et al. (1998) Roles of Rho-associated kinase in cytokinesis; mutations in Rho-associated kinase phosphorylation sites impair cytokinetic segregation of glial filaments. J. Cell Biol. 143:1249-58.
3. Loirand G, Guerin P, Pacaud P. (2006) Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 98:322-34.
4. Bao W, et al. (2004) Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc. Res. 61:548-58.
5. Zhang J, et al. (2009) Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation. Clin. Chim. Acta. 401:76-80.
6. Murry CE, Jennings RB, Reimer KA. (1986) Pre-conditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1124-36.
7. An J, Varadarajan SG, Novalija E, Stowe DF. (2001) Ischemic and anesthetic preconditioning reduces cytosolic [Ca2+] and improves Ca(2+) responses in intact hearts. Am. J. Physiol. Heart Circ. Physiol. 281: H1508-23.
8. Sanada S, et al. (2004) Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation. 110:51-7.
9. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-94.
10. Demiryurek S, et al. (2005) Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats. Eur. J. Pharmacol. 527:129-40.
11. Ji ES, Yue H, Wu YM, He RR. (2004) Effects of phytoestrogen genistein on myocardial ischemia/ reperfusion injury and apoptosis in rabbits. Acta Pharmacol. Sin. 25:306-12.
12. Mohanty I, Arya DS, Gupta SK. (2006) Effect of Curcuma longa and Ocimum sanctum on myocardial apoptosis in experimentally induced myocardial ischemic-reperfusion injury. BMC Complement. Altern. Med. 6:3.
13. Chomczynski P. (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 15:532-4, 536-7.
14. Erwig LP, et al. (2006) Differential regulation of phagosome maturation in macrophages and dendritic cells mediated by Rho GTPases and ezrinradixin-moesin (ERM) proteins. Proc. Natl. Acad. Sci. U. S. A. 103:12825-30.
15. Tosello-Trampont AC, Nakada-Tsukui K, Ravichandran KS. (2003) Engulfment of apoptotic cells is negatively regulated by Rhomediated signaling. J. Biol. Chem. 278:49911-19.
16. Song ZF, et al. (2008) Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury via suppressing JNK-mediated AIF translocation. J. Cell Mol. Med. 12:1220-8.
17. Matsui T, et al. (1996) Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 15:2208-16.
18. Coleman ML, et al. (2001) Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3:339-45.
19. Sahai E, Olson MF, Marshall CJ. (2001) Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20:755-66.
20. Piazzolla D, Meissl K, Kucerova L, Rubiolo C, Baccarini M. (2005) Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signaling. J. Cell Biol. 171:1013-22.
21. Manapov F, Muller P, Rychly J. (2005) Translocation of p21(Cip1/WAF1) from the nucleus to the cytoplasm correlates with pancreatic myofibroblast to fibroblast cell conversion. Gut. 54:814-22.
22. Vial E, Sahai E, Marshall CJ. (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell. 4:67-79.
23. Mavria G, et al. (2006) ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell. 9:33-44.
24. Boulton TG, et al. (1990) An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science. 249:64-7.
25. Torii S, Nakayama K, Yamamoto T, Nishida E. (2004) Regulatory mechanisms and function of ERK MAP kinases. J. Biochem. 136:557-61.
26. Sugden PH, Clerk A. (2006) Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes. Antioxid. Redox. Signal. 8:2111-24.
27. Bueno OF, Molkentin JD. (2002) Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91:776-81.
28. Lips DJ, et al. (2004) MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation. 109:1938-41.
29. Harris IS, et al. (2004) Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload. Circulation. 110:718-23.
30. Yamaguchi O, et al. (2004) Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis. J. Clin. Invest. 114:937-43.
31. Yue TL, et al. (2000) Inhibition of extracellular signal-regulated kinase enhances ischemia/ reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 86:692-9.
32. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am. J. Physiol. Heart Circ. Physiol. 288:H971-6.
33. Mocanu MM, Bell RM, Yellon DM. (2002) PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J. Mol. Cell. Cardiol. 34:661-8.
34. Hausenloy DJ, Yellon DM. (2004) New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc. Res. 61:448-60.